Oxford Glycosciences Plc

OGS was founded in 1988 and floated on the London Stock Excange in 1998. OGS became a leader in the emerging field of proteomics, the comprehensive study of proteins. OGS successfully integrated proteomics with genomics to create an innovative, proprietary drug discovery platform to allow the systematic separation, identification and characterisation of proteins on an industrial scale. Oxford Glycosciences was acquired by Celltech plc in July 2003 for £102 m. Celltech was acquired by Belgian company UCB SA.